Bicocca Open Archive

Logo unimib boa
LISSONI, ANDREA ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.069
EU - Europa 3.451
AS - Asia 1.415
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 6
OC - Oceania 3
Totale 13.968
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.900
IT - Italia 631
CN - Cina 608
SE - Svezia 498
UA - Ucraina 479
IE - Irlanda 469
SG - Singapore 417
DE - Germania 383
RU - Federazione Russa 370
HK - Hong Kong 200
GB - Regno Unito 175
CA - Canada 167
FI - Finlandia 129
AT - Austria 108
VN - Vietnam 79
FR - Francia 68
DK - Danimarca 45
NL - Olanda 37
IN - India 34
TR - Turchia 25
BE - Belgio 20
JP - Giappone 14
BR - Brasile 12
EU - Europa 9
PL - Polonia 9
ES - Italia 8
IR - Iran 8
KR - Corea 8
ID - Indonesia 6
RO - Romania 5
TW - Taiwan 4
AU - Australia 3
CH - Svizzera 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
IL - Israele 2
MA - Marocco 2
OM - Oman 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
DO - Repubblica Dominicana 1
EC - Ecuador 1
GR - Grecia 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
MX - Messico 1
PH - Filippine 1
PK - Pakistan 1
Totale 13.968
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.843
Woodbridge 1.187
Fairfield 676
Houston 663
Jacksonville 519
Dublin 437
Chandler 414
Wilmington 399
Ashburn 351
Singapore 343
Dearborn 335
Seattle 293
Frankfurt am Main 270
Cambridge 255
Princeton 218
New York 206
Hong Kong 189
Santa Clara 156
Milan 153
Vienna 108
Altamura 106
Lawrence 104
Nanjing 104
Lachine 91
Shanghai 78
Beijing 74
Fremont 49
Andover 46
Boardman 46
San Diego 43
Nanchang 37
Helsinki 36
Ottawa 36
Hebei 34
Toronto 29
Guangzhou 28
Jiaxing 28
Shenyang 27
Changsha 23
Huizen 22
Rome 22
London 21
Tianjin 21
Los Angeles 20
Brussels 19
Falls Church 19
Norwalk 18
Kunming 17
Lissone 17
Dallas 16
Detroit 15
Chicago 14
Dong Ket 14
Hangzhou 14
Pune 14
Mountain View 13
Florence 10
Munich 10
Shenzhen 10
Jinan 9
University Park 9
Auburn Hills 8
Redmond 8
Zhengzhou 8
Edmonton 7
Lanzhou 7
Leawood 7
Moscow 7
Desio 6
Jakarta 6
Kiev 6
Palermo 6
Sacramento 6
San Mateo 6
Amsterdam 5
Cinisello Balsamo 5
Fuzhou 5
Hefei 5
Hounslow 5
Kraków 5
Taizhou 5
Tappahannock 5
Torre Del Greco 5
Verona 5
Wallington 5
Brescia 4
Changchun 4
Chiswick 4
Garbagnate Milanese 4
Miami 4
Naples 4
Ningbo 4
Padova 4
Prescot 4
Seregno 4
Taipei 4
Turin 4
Zanjan 4
Ankara 3
Carate Brianza 3
Totale 10.579
Salva come PNG Salva come JPEG
Nome #
High-dose epirubicin in patients with advanced or recurrent uterine sarcoma 486
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 363
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms 289
Potential role of BCL2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential 251
Genomic and epigenomic profile of uterine smooth muscle tumors of uncertain malignant potential (Stumps) revealed similarities and differences with leiomyomas and leiomyosarcomas 251
Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine production 232
Clinical outcome of patients with malignant tumors associated with mature cystic teratomas of the ovary: A retrospective multicenter Italian study 230
From Conventional Radiotracer Tc-99m with Blue Dye to Indocyanine Green Fluorescence: A Comparison of Methods Towards Optimization of Sentinel Lymph Node Mapping in Early Stage Cervical Cancer for a Laparoscopic Approach 207
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial 206
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 201
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer 195
Imact of bevacizumab-containing primary treatment on outcome of recurrent ovarian cancer: An Italian study 183
Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer 179
OC13. 02: Reproducibility of IETA terms in describing endometrial pathology 176
Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancer 171
Early and short-term complications after US-guided puncture of gynecologic lesions: evaluation after 1,000 consecutive cases 170
Uterine leiomyosarcoma: analysis of treatment failures and survival 167
Pre-operative morphological and colour Doppler features of borderline ovarian tumours 167
Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors 163
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group 159
Sentinel lymph node detection in endometrial cancer: hysteroscopic peritumoral versus cervical injection 158
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale 157
Prospective multicenter study on the clinical utility of CA 72.4 in post-menopausal patients with pelvic mass 155
External validation of diagnostic models to estimate the risk of malignancy in adnexal masses 151
Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study 150
Proliferative response of lymphocytes from ovarian cancer patients to autologous tumor cells 150
Prospective multicenter study on CA 125 in postmenopausal pelvic masses 148
Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale 147
Role of puncture and aspiration in expectant management of simple ovarian cysts: a randomised study 146
Brachytherapy for isolated vaginal recurrences from endometrial carcinoma 144
Synchronous early-stage endometrial and ovarian cancer 143
Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma 143
Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy 142
Long-term clinical benefits of neoadjuvant chemotherapy in women with locally advanced cervical cancer: Validity of pathological response as surrogate endpoint of survival 142
Dose-dense neoadjuvant chemotherapy with paclitaxel and carboplatin in cervical cancer: Efficacy on pathological response 141
Long-term toxicity and health-related quality of life after adjuvant chemoradiotherapy or radiotherapy alone for high-risk endometrial cancer in the randomised PORTEC-3 trial 140
Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy 136
Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies 135
Endometrial stromal sarcoma: analysis of treatment failures and survival 135
Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help 134
Long-term results of a multicenter SAKK trial on high-dose ifosfamide and doxorubicin in advanced or metastatic gynecologic sarcomas 133
Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma 133
Safety of transvaginal fine needle puncture of gynecologic masses: a report after 500 consecutive procedures 133
Antiemetic efficacy of granisetron in patients with gynecological malignancies 130
Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients 129
Color Doppler ultrasound in the preoperative assessment of adnexal masses 128
Optimal treatment of early-stage ovarian cancer 127
Ovarian cancer prediction in adnexal masses using ultrasound based logistic regression models: a temporal and external validation study by the IOTA group 126
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis 126
Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses 126
Ultrasound in the follow-up of young patients with malignant ovarian tumors after conservative surgery 125
Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study 125
A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer 124
Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis 124
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study 123
Changes in the management and outcome of central nervous system involvement from ovarian cancer since 1994 115
Ultrasound characteristics of endometrial hyperplasia described using IETA terms 115
Endometriomas: Their ultrasound characteristics 114
Effectiveness of autologous blood transfusion in patients undergoing radical hysterectomy 113
International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer 113
Primary malignant vaginal melanoma treated with adriamycin and ifosfamide: a case report and literature review 112
Imaging in gynecological disease (7): clinical and ultrasound features of Brenner tumors of the ovary 112
Primary carcinoma of the fallopian tube. A retrospective analysis of 47 patients 112
Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer patients 111
Clinically oriented three-step strategy to the assessment of adnexal pathology 110
Alpha-fetoprotein in the management of germ cell tumors of the ovary 109
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes 108
The prognostic relevance of histological type in uterine sarcomas: A cooperation task force (CTF) multivariate analysis of 249 cases 108
Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells 108
Second-look laparotomy in the management of fallopian tube carcinoma 106
Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma 106
Transvaginal ultrasonographic characterization of ovarian masses: comparison of five scoring systems in a multicenter study 105
Brain metastases from endometrial carcinoma 104
Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients 102
Modified radical hysterectomy versus extrafascial hysterectomy in the treatment of stage I endometrial cancer: results from the ILIADE randomized study 100
Ifosfamide in the treatment of malignant epithelial ovarian tumors 98
A novel approach to predict the likelihood of specific ovarian tumor pathology based on serum CA-125: a multicenter observational study 98
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel 98
Metabolism of tumour-derived urokinase receptor and receptor fragments in cancer patients and xenografted mice 96
Tumor volume as risk factor for nodal diffusion in endometrial cancer 96
Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses?: an Italian multicentric retrospective analysis 94
Detection of abnormal intrauterine vascularization by color Doppler imaging: A possible additional aid for the follow up of patients with gestational trophoblastic tumors 93
Unilocular adnexal cysts with papillary projections but no other solid components: is there a diagnostic method that can reliably classify them as benign or malignant before surgery? 93
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 90
Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas 89
ΔNp63 expression is associated with poor survival in ovarian cancer 86
Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel 84
Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer 82
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial 82
Neoplasie dell’apparato genitale femminile 82
Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer 78
Fertility-sparing surgery in uterine leiomyosarcoma 77
Comparison of methods for monitoring young women with stage I borderline ovarian tumor after conservative surgery 76
Surgical resection of solitary brain metastasis from ovarian carcinoma: an analysis of 22 cases 76
Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial 74
Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females 74
Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer 74
Total neuropathy scale items as early predictors of chemotherapy‐induced peripheral neurotoxicity 73
A prospective study of the role of ultrasound in the management of adnexal masses in pregnancy 73
The risk of malignancy in unilocular cysts: a study on 1148 adnexal masses classified as unilocular cysts at transvaginal scan with review of the literature 70
Totale 13.544
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.527
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.527
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.801 0 0 0 0 268 335 369 191 286 119 187 46
2020/20211.887 124 82 178 186 122 153 192 179 195 208 109 159
2021/20221.185 74 91 81 112 105 94 55 91 56 85 108 233
2022/20231.892 256 577 134 137 182 297 13 90 125 17 31 33
2023/20241.380 38 43 77 73 181 353 264 33 133 39 19 127
2024/20251.374 195 512 184 191 292 0 0 0 0 0 0 0
Totale 14.354